Company Performance Metrics
Qurin is dedicated to realizing the full potential of early cancer detection—identifying cancer when treatments are most effective and less costly. While others focus on detecting a cancer signal, we specialize in ensuring there is a cancer signal to detect—the critical first step in any diagnostic test. Our technology is 10x more convenient for
patients, delivers 10x more biomarkers, and is 10x easier to process in the lab. This allows us to leverage existing investments in early cancer diagnostic tests and amplify the impact of biomarkers and analytical technologies.
We prioritize cancers with high unmet need, starting with bladder cancer. Beyond oncology, we make our biomarker extraction and pre-concentration technology available to companies working on a broad range of applications.
For more information, visit: https://www.qurin.com
